Answers are grounded in this paper and cite their sources.
Cochrane Review evaluates benefits of bone marrow-sparing radiotherapy in women with cervical cancer, suggesting improved outcomes.
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To evaluate the benefits and harms of bone marrow-sparing radiotherapy compared with non-bone marrow-sparing radiotherapy in women with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Secondary objectives To investigate whether effects differ according to clinical, histopathological, and technical characteristics, focusing on: acute haematologic toxicity; acute gastrointestinal and genitourinary toxicity; and bone marrow dose-volume parameters associated with acute haematologic toxicity, including exploration of dose-volume ranges relevant for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Cantídio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: